Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients.
about
Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunityHuman immunodeficiency virus and liver disease forum 2010: conference proceedingsTreatment of chronic hepatitis C in HIV-infected patients with compensated liver cirrhosis.Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy.Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia.The hepatitis C cascade of care: identifying priorities to improve clinical outcomesThe cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients.Cost-effective screening for acute hepatitis C virus infection in HIV-infected men who have sex with men.Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programsHCV and HIV co-infection: mechanisms and management.Clinical impact of treatment timing for chronic hepatitis C infection: a decision modelMELD Score Kinetics in Decompensated HIV+/HCV+ Patients: A Useful Prognostic Tool (ANRS HC EP 25 PRETHEVIC Cohort Study).Dimension of chronic hepatitis C virus in HIV-infected patients in the interferon-free era: an overview from south Spain.Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: a multicenter regional simulationClinical Liver Disease Progression Among Hepatitis C-Infected Drug Users With CD4 Cell Count Less Than 200 Cells/mm(3) Is More Pronounced Among Women Than Men.Cirrhosis and liver transplantation in patients co-infected with HIV and hepatitis B or C: an observational cohort study.HIV and hepatitis C virus: special concerns for patients with cirrhosis.After the cure: management of HCV after achievement of SVR.Virologic and immunologic aspects of HIV-hepatitis C virus coinfection.The effect of hepatitis C treatment and human immunodeficiency virus (HIV) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam.Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short term.The cost-effectiveness of one-time hepatitis C screening strategies among adolescents and young adults in primary care settings.HCV RNA viral load is independent from CD4 cell count and plasma HIV RNA viral load in immunocompetent HIV-HCV co-infected patients: a 3-years follow-up study.Reversible hepatic decompensation following cessation of antiretroviral therapy in a patient with HIV and hepatitis C co-infection.Progression of liver fibrosis in HIV/hepatitis C virus-coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline.Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis.Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus-coinfected patients with compensated cirrhosis.Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study.Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy.
P2860
Q26773267-82E4F3BA-F5C9-45F7-B5EF-CFB1ABB3351CQ28674930-EBD0312B-7194-4C5F-B4A4-29044F26E86FQ33391761-345384E0-4501-4CE4-A183-C47E583FB9C0Q33422417-C898CF15-BCD2-4FC8-BD05-CE33CBB54F71Q33423922-220A38C5-0D9D-4419-9E2F-24ED3FFF0F96Q33632459-A4E9D3B8-E998-487B-B501-CFFCD9D1CD7DQ33710740-EAF043DE-51EB-44EE-BE1B-E3E160E380A1Q34227450-E4E15942-DA68-482B-BE36-A4412F63D877Q34735072-042F1924-E3AA-4C37-8D88-80813D88C42EQ35090634-2D297A0A-AC66-4DFC-BB52-319ACD909591Q35889164-39234152-1FE1-49CC-9889-C229225A0F70Q36009355-34BE0303-9646-46C5-AC9C-C13279990824Q36167452-F75ADD7D-72EF-4A61-993D-41CD925E08C8Q36444618-55A44A4D-5D6C-401F-B266-4F45A4358CF5Q36650557-F5D67031-4494-4E77-8CD0-D9080DB91A50Q37730962-643D1C53-9E9D-4D51-876C-5C7CAF9F4026Q38079809-D61B23A5-36FE-413E-B91E-0A6363C6247AQ38161848-9588CCD1-65BD-4C8F-9D58-A6E9D28800D5Q38900456-4C86A584-0F5F-4B4C-8C45-2EBDDCC95E26Q39707313-AF02B998-4CFE-4116-82C3-AA53F4E080CBQ41578791-57C19504-5DCD-41DD-9644-8378A2DD338CQ41919051-C203055E-3A19-40F9-B03A-F2B6C6B1333EQ41984358-8EA1FA7E-FDB1-46C4-BC74-35ED5A39A3B8Q42240161-247F54F1-4E5C-49C4-8A04-14EE754EF9EDQ42254827-EB07E98A-9F9E-4C98-8B60-8DA6AAF4CBE4Q42977116-A90FF021-5436-40A2-A4F1-9B0590719025Q42989479-11C68E86-466B-4D92-8355-0204D141455AQ49725940-08C28F03-1DB9-4E9E-B78F-73EC5F7AB55CQ49823266-460BF56C-8A06-4634-AC22-6BF07AA0D981
P2860
Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Natural history of compensated ...... osis in HIV-infected patients.
@en
Natural history of compensated ...... osis in HIV-infected patients.
@nl
type
label
Natural history of compensated ...... osis in HIV-infected patients.
@en
Natural history of compensated ...... osis in HIV-infected patients.
@nl
prefLabel
Natural history of compensated ...... osis in HIV-infected patients.
@en
Natural history of compensated ...... osis in HIV-infected patients.
@nl
P2093
P50
P356
P1476
Natural history of compensated ...... hosis in HIV-infected patients
@en
P2093
Angela Camacho
Dolores Merino
Grupo para el Estudio de las H ...... za de Enfermedades Infecciosas
Josefa Ruiz-Morales
José Del Valle
Manuela Aguilar-Guisado
María J Ríos-Villegas
P304
P356
10.1086/605676
P407
P50
P577
2009-10-01T00:00:00Z